During the past decade, Australian Clinical Trials conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Australian Clinical Trials" #1 sponsor was "Pfizer" with 3 trials, followed by "Alessa Therapeutics Inc." with 1 trials sponsored, "MedeonBio, Inc." with 1 trials sponsored, "University of Sydney" with 1 trials sponsored and "Zenflow, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Australian Clinical Trials" #1 collaborator was "Astellas Pharma Inc" with 3 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 3 trials as a collaborator and "Australian and New Zealand Urogenital and Prostate Cancer Trials Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Australian Clinical Trials" are "Prostate Cancer" (3 trials), "Benign Prostatic Hyperplasia" (2 trials), "Cancer of the Prostate" (2 trials), "Cancer" (1 trials) and "Hormone Sensitive Prostate Cancer" (1 trials). Many other conditions were trialed in "Australian Clinical Trials" in a lesser frequency.

Most popular intervention types in "Australian Clinical Trials" are "Drug" (4 trials), "Device" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Enzalutamide" (3 trials), "Bicalutamide implant" (1 trials), "Leuprolide" (1 trials) and "Methoxyflurane" (1 trials). Other intervention names were less common.

The vast majority of trials in "Australian Clinical Trials" are 7 trials for "Male" genders.

Currently, there are NaN active trials in "Australian Clinical Trials". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Australian Clinical Trials, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Australian Clinical Trials, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".